| Dec 23 2014 |
Ho Ho Ho GMO! The 2014 GMO Legislation Scorecard |
Mintz |
| Dec 20 2014 |
Myriad's Breast Cancer Test Patents Not Patent Eligible |
Honigman Miller Schwartz and Cohn LLP |
| Dec 19 2014 |
Supreme Court Asked To Decide Whether Colorado’s Marijuana Legalization Violates Constitution |
Jackson Lewis P.C. |
| Dec 19 2014 |
CME Issues Revisions to Wash Trade Advisory Notice |
Katten |
| Dec 19 2014 |
Legalized Loophole – Is Legalized Marijuana Truly “Lawful?” |
Barnes & Thornburg LLP |
| Dec 19 2014 |
Buy High, Sell Low, and Restrict Competition: The Allegations Underlying the Government’s Case Against DaVita and the Implications of the Settlement |
Faegre Drinker |
| Dec 19 2014 |
Generally Accepted Processing Practice (GAPP) Improves Michigan Food Processing |
Varnum LLP |
| Dec 19 2014 |
CMS Issues Rewards and Incentive Guidance to Medicare Advantage (MA) Plans |
Mintz |
| Dec 19 2014 |
U.S. Commerce Department Prioritizes Mozambique in 2015 |
Covington & Burling LLP |
| Dec 18 2014 |
2014 Interim Guidance on Patent Subject Matter Eligibility Under Myriad and Nature-Based Products |
Barnes & Thornburg LLP |
| Dec 18 2014 |
Revised Guidelines for Patentable Subject Matter Eligibility |
Vedder Price |
| Dec 18 2014 |
Federal Spending Bill Creates Controversy Over Federal Government’s Position on Medical Marijuana |
Jackson Lewis P.C. |
| Dec 18 2014 |
Indonesia — Can it Unleash Needed Investment? |
Covington & Burling LLP |
| Dec 18 2014 |
Mayo Meet Alice Meet Myriad – Fed. Cir. Appreciates “Abstract Art” |
Schwegman, Lundberg & Woessner, P.A. |
| Dec 18 2014 |
Update: Syngenta Litigation Regarding GMO Corn |
Mintz |
| Dec 18 2014 |
One Step Closer to Normalizing Relations with Cuba |
Faegre Drinker |
| Dec 17 2014 |
30 Projects Announced to Support Michigan Specialty Crop Growers |
Varnum LLP |
| Dec 16 2014 |
USPTO Issues New Subject Matter Eligibility Examination Interim Guidelines – Nature-Based Product Guidance |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Dec 16 2014 |
Tech Conference Helps Philadelphia Gain Ground in Attracting Israeli Companies |
Greenberg Traurig, LLP |
| Dec 16 2014 |
Sandoz and Celltrion Decline the Invitation to Dance: Biosimilars Challenge the Applicability of the BPCIA’s Exchange Provisions Before Bringing Suit |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 16 2014 |
North Carolina Court of Appeals: Restrictive Covenant Prohibiting "Store" Does Not Prohibit "Parking" for a Prohibited Store |
Womble Bond Dickinson (US) LLP |
| Dec 16 2014 |
PTO Litigation Center Report – December 16, 2014 |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Dec 15 2014 |
Vermont Doubles Down: Representative Testifies Before Congress Against Federal GMO Labeling Bill |
Mintz |
| Dec 15 2014 |
Sunshine Act Update: CMS Streamlines Reporting for CME-Related Payments in 2016 |
Morgan, Lewis & Bockius LLP |
| Dec 15 2014 |
Proposed Privacy Fences Around Michigan Apiaries |
Varnum LLP |
| Dec 14 2014 |
Ebola: U.S. Provider Protocol and National Response Update |
Greenberg Traurig, LLP |
| Dec 13 2014 |
FDA Issues Two Final Rules to Help Consumers Keep Track of Calories |
Greenberg Traurig, LLP |
| Dec 13 2014 |
New Jersey Medical Devices Company and Former CEO to Pay $80 Million for Alleged Illegal Distribution of Knee Replacement Apparatus |
Tycko & Zavareei LLP |
| Dec 13 2014 |
Comprehensive New EU Food Labeling Regulation Goes Into Effect December 13 |
Covington & Burling LLP |
| Dec 12 2014 |
Ninth Circuit Clarifies Scope of Mass Action Federal Jurisdiction and Removal |
Greenberg Traurig, LLP |
| Dec 12 2014 |
Great Lakes Ag-Tech Business Incubator Helps Entrepreneurial Farmers |
Varnum LLP |
| Dec 12 2014 |
Supreme Court to Review Post-Expiration Date Royalties in Kimble v. Marvell |
Schwegman, Lundberg & Woessner, P.A. |
| Dec 11 2014 |
Guidelines Regarding Advanced Practice Registered Nurses (APRNs) Prescribing Hydrocodone |
McBrayer, McGinnis, Leslie and Kirkland, PLLC |
| Dec 10 2014 |
Dole Defeats “All Natural Claims” for Sweet Victory |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 10 2014 |
Federal Circuit’s Sandoz Decision Increases Importance of Post-Grant Proceedings to Biosimilar Developers |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
